Search Within

Daniel C Danila

  1. "2022"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
  3. Book Section (1)
Groups
  1. Department of Medicine (8)
  2. Genitourinary Oncology Service (8)
  3. Solid Tumor Oncology Division (8)
  4. Epidemiology and Biostatistics (3)
  5. Hematologic Malignancies, Division of (3)
  6. Sloan Kettering Institute Postdocs (3)

More Groups

People
  1. Howard Scher (5)
  2. Michael Morris (4)
  3. Barbara Nweji (3)
  4. Dana Rathkopf (3)
  5. Karen Autio (3)
  6. Konrad Stopsack (3)

More People

Years
  1. 2022 (8)
Publications
  1. Journal of Clinical Oncology (2)
  2. Annals of Oncology (1)
  3. Cancer Biomarkers: Clinical Aspects and Laboratory Determination (1)
  4. Clinical Cancer Research (1)
  5. Clinical Genitourinary Cancer (1)
  6. Lancet Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (2)
  2. Elsevier Inc. (2)
  3. American Association for Cancer Research (1)
  4. Elsevier Science, Inc. (1)
  5. John Wiley & Sons (1)
  6. Oxford University Press (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Gupta, S.; Yang, Q.; Halabi, S.; Tubbs, A.; Gore, Y.; George, D. J.; Nanus, D. M.; Antonarakis, E. S.; Danila, D.; Szmulewitz, R.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1 study of AMG 509 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Danila, D. C.; Waterhouse, D. M.; Appleman, L. J.; Pook, D. W.; Matsubara, N.; Dorff, T. B.; Lee, J. L.; Armstrong, A. J.; Kim, M.; Horvath, L.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • PSA: Role in screening and monitoring patients with prostate cancer
    Book Section

    Carlsson, S. V.; Murata, K.; Danila, D. C.; Lilja, H.
    In Ramanathan, L. V.; Fleisher, M.; Duffy, M. J. (Eds.) Cancer Biomarkers: Clinical Aspects and Laboratory Determination (2022)

    Fulltext@MSK | Save
  • Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): A multicentre, open-label, phase 2 trial
    Journal Article

    Smith, M. R.; Scher, H. I.; Sandhu, S.; Efstathiou, E.; Lara, P. N. Jr; Yu, E. Y.; George, D. J.; Chi, K. N.; Saad, F.; Ståhl, O.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality
    Journal Article

    Keegan, N. M.; Vasselman, S. E.; Barnett, E. S.; Nweji, B.; Carbone, E. A.; Blum, A.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; more...
    Prostate (2022)

    Fulltext@MSK | Save
  • Automated bone scan index to optimize prostate cancer working group radiographic progression criteria for men with metastatic castration-resistant prostate cancer
    Journal Article

    Anand, A.; Heller, G.; Fox, J.; Danila, D. C.; Bjartell, A.; Edenbrandt, L.; Larson, S. M.; Scher, H. I.; Morris, M. J.
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality
    Meeting Abstract

    Keegan, N. M.; Vasselman, S. E.; Barnett, E.; Nweji, B.; Carbone, E.; Blum, A.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save